Vericel Corp. (VCEL)
36.01
-0.72
(-1.96%)
USD |
NASDAQ |
Dec 31, 16:00
36.00
0.00 (0.00%)
Pre-Market: 20:00
Vericel Shareholders Equity (Quarterly): 321.86M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 431.19M |
| Vanda Pharmaceuticals, Inc. | 466.00M |
| Marker Therapeutics, Inc. | 18.39M |
| Veracyte, Inc. | 1.258B |
| Aldeyra Therapeutics, Inc. | 49.24M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 453.27M |
| Total Liabilities (Quarterly) | 131.42M |
| Debt to Equity Ratio | 0.3101 |
| Current Ratio | 4.870 |
| Net Debt Paydown Yield | -0.05% |